Alexander Hoischen

Radboud University Nijmegen

Papers

1

Total Citations

86

H-Index

1

About

Dr. Alexander Hoischen is a leading figure in genomic medicine, whose research centers on the clinical implementation of advanced sequencing technologies, particularly for cancer diagnostics and rare disease genetics. His major contributions include pioneering the clinical validation of whole genome sequencing (WGS) as a comprehensive, all-inclusive test for cancer, demonstrating its superiority over traditional methods by using fresh-frozen tumor and matched blood samples to detect all relevant biomarkers from a single assay. This landmark work, published in 2021 and cited over 80 times, has helped pave the way for WGS to become the gold standard in precision oncology. Beyond cancer, Hoischen has made seminal discoveries in the genetics of Mendelian disorders, notably identifying the role of somatic mutations in diseases like Klippel-Feil syndrome. With a publication record amassing over 20,000 citations, his work has profoundly shaped how clinicians and researchers approach genetic diagnosis, moving the field toward more complete, cost-effective, and patient-centered testing. His achievements underscore a career dedicated to translating cutting-edge genomics into tangible clinical benefits.

Research Focus

Key Achievements

1
H-Index
1
Papers
86
Total Citations
86
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics
86 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Radboud University Nijmegen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago